Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.96%
#2 aelf aelf +23.43%
#3 Bitway Bitway +23.30%
#4 Pons Pons +14.07%
#5 Starpower Starpower +13.59%
#6 Decred Decred +13.55%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +12.19%
#8 TRIA TRIA +10.92%
#9 AtomOne AtomOne +9.50%
#10 DAPPOS DAPPOS +8.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

PIQ
Rang în acțiuni #30135
Proteomics International Laboratories Ltd operates as a medical technology... Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.
Preț acțiune
$0.11284557
Capitalizare de piață
$18.66M
Schimbare (1 zi)
3.23%
Schimbare (1 an)
-47.82%
Țară
AU
Tranzacționează Proteomics International Laboratories Ltd. (PIQ)

Categorie

Healthcare
Istoricul spliturilor pentru Proteomics International Laboratories Ltd. (PIQ)
Acțiunea Proteomics International Laboratories Ltd. (simbol: PIQ) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 19, 2026.
O acțiune PIQ cumpărată înainte de Aug 19, 2026 este echivalentă astăzi cu 0 acțiuni PIQ.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
HCA Healthcare, Inc. HCA Healthcare, Inc.
HCA Healthcare, Inc.
HCA.US
 0 -
US
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
FRE.DE
 0 -
DE
Dr. Sulaiman Al Habib Medical Services Group Company Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company
4013.SR
 0 -
SA
Tenet Healthcare Corporation Tenet Healthcare Corporation
Tenet Healthcare Corporation
THC.US
 12 x7
US
IHH Healthcare Berhad IHH Healthcare Berhad
IHH Healthcare Berhad
5225.KL
 0 -
MY